Bio€quity Europe

Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected Presenting Companies.

Now celebrating its 19th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. Delegates from 24 nations attended Bio€quity Europe last year in Paris.

The life sciences and healthcare industry is constantly searching for new medical solutions. At the same time, cost-efficient and affordable healthcare is a bigger challenge than ever. As the leading independent merchant bank in European Life Sciences & Healthcare, Kempen has a dedicated sector team specialized in this growth market.

 Bio€quity Europe


More on

Kempen Life Sciences & Healthcare


Jan De Kerpel